<code id='C5CCAF4AB0'></code><style id='C5CCAF4AB0'></style>
    • <acronym id='C5CCAF4AB0'></acronym>
      <center id='C5CCAF4AB0'><center id='C5CCAF4AB0'><tfoot id='C5CCAF4AB0'></tfoot></center><abbr id='C5CCAF4AB0'><dir id='C5CCAF4AB0'><tfoot id='C5CCAF4AB0'></tfoot><noframes id='C5CCAF4AB0'>

    • <optgroup id='C5CCAF4AB0'><strike id='C5CCAF4AB0'><sup id='C5CCAF4AB0'></sup></strike><code id='C5CCAF4AB0'></code></optgroup>
        1. <b id='C5CCAF4AB0'><label id='C5CCAF4AB0'><select id='C5CCAF4AB0'><dt id='C5CCAF4AB0'><span id='C5CCAF4AB0'></span></dt></select></label></b><u id='C5CCAF4AB0'></u>
          <i id='C5CCAF4AB0'><strike id='C5CCAF4AB0'><tt id='C5CCAF4AB0'><pre id='C5CCAF4AB0'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:563
          Stock ticker
          Adobe

          You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

          ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

          advertisement

          What if sometimes cancer doctors could give less medicine?

          Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          National associations that represent hospice owe an apology
          National associations that represent hospice owe an apology

          JohnMoore/GettyImages“Howhastheclinicalworkyoudoaffectedyoupersonally?”We’dcometotheQ&Apartofthe

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          What past blockbusters can tell us about future of Wegovy and other weight loss medicines

          MollyFergusonforSTATThenewsthattheweightlossdrugWegovyreducedtheriskofheartattacksandstrokesinoverwe